Used in the treatment of relapsing forms of multiple sclerosis. It helps reduce the frequency of clinical relapses and delays the progression of physical disability. The compound acts as a prodrug, releasing the active metabolite monomethyl fumarate in the body, which has anti-inflammatory and neuroprotective effects. It is taken orally and is designed to have improved gastrointestinal tolerability compared to similar fumarate-based therapies.